Search results
Hill is a leader in the field of malaria vaccine development and was a co-leader of the research team which produced the Oxford–AstraZeneca COVID-19 vaccine, along with Professor Sarah Gilbert of the Jenner Institute and Professor Andrew Pollard of the Oxford Vaccine Group.
Feb 1, 2021 · Single Dose Administration, And The Influence Of The Timing Of The Booster Dose On Immunogenicity and Efficacy Of ChAdOx1 nCoV-19 (AZD1222) Vaccine. Number of pages: 37 Posted: 01 Feb 2021.
Employment (1) sort Sort. University of Oxford: Oxford, GB. 1988-08-01 to present | Director, PI (Jenner Institute and Wellcome Human Genetics Centre) Employment. Show more detail. Source : Adrian V. S. Hill. expand_more. Works (43) sort Sort.
Jan 28, 2022 · Adrian V. S. Hill has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
Adrian V.S. Hill is a Professor of Human Genetics and Director of the Jenner Institute, University of Oxford, who leads research programmes in vaccine development and the genetics of susceptibility to tropical infectious diseases.
Our analyses demonstrate a substantial degree of heritability (pooled polygenic h ² = 26.3%, 95% CI 23.7–29.0%) for susceptibility to TB that is shared across ancestries, highlighting an ...
Adrian V. S. Hill's Lab. Advance your research. Featured research (1) Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2,...
